The findings reveal that PCC deficiency can severely disrupt some of the ionic mechanisms that control cardiac excitability, AP duration (APD), and cytosolic Ca2+ handling at the cellular level, thus heightening the risk of arrhythmias independently of the late‐onset cardiomyopathy progression characteristic of the disease. The gene discussed is CRYGD; the disease is cardiomyopathy.